| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0021 | 0.9 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.002 | 0.9 |